Statins and ARBs on Rheumatoid Activity

Summary

Statins and ARBs on Rheumatoid Activity is a clinical trial^[1].

Key Facts

• Statins and ARBs on Rheumatoid Activity is in the country of Egypt^[2].
• Statins and ARBs on Rheumatoid Activity's instance of is recorded as clinical trial^[3].
• Statins and ARBs on Rheumatoid Activity's start time is recorded as +2018-10-01T00:00:00Z^[4].
• Statins and ARBs on Rheumatoid Activity's end time is recorded as +2025-12-01T00:00:00Z^[5].
• Statins and ARBs on Rheumatoid Activity's sponsor is recorded as Sherief Abd-Elsalam^[6].
• Statins and ARBs on Rheumatoid Activity's main subject is recorded as arthritis^[7].
• Statins and ARBs on Rheumatoid Activity's number of participants is recorded as {'unit': '1', 'amount': '+45'}^[8].
• Statins and ARBs on Rheumatoid Activity's title is recorded as Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients^[9].
• Statins and ARBs on Rheumatoid Activity's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[10].
• Statins and ARBs on Rheumatoid Activity's ClinicalTrials.gov ID is recorded as NCT03770702^[11].
• Statins and ARBs on Rheumatoid Activity's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}^[12].
• Statins and ARBs on Rheumatoid Activity's research intervention is recorded as statin^[13].
• Statins and ARBs on Rheumatoid Activity's research intervention is recorded as angiotensin receptor antagonist^[14].
• Statins and ARBs on Rheumatoid Activity's clinical trial phase is recorded as phase III clinical trial^[15].
• Statins and ARBs on Rheumatoid Activity's research subject recruitment status is recorded as recruiting^[16].
• Statins and ARBs on Rheumatoid Activity's study type is recorded as interventional study^[17].